Invokana & Kidney Failure / Ketoacidosis
Insight from Cleveland Dangerous Drug Attorneys
Spangenberg Shibley & Liber takes cases involving dangerous drugs seriously, especially when these drugs cause harm or injuries to innocent health consumers. That is why our firm is investigating the link between type 2 diabetes medicines such as Invokana and kidney failure, ketoacidosis, and other serious injuries.
Some of these medicines include the following:
- Invokana (canagliflozin)
- Invokamet (canagliflozin/metformin)
- Jardiance (empagliflozin)
- Xigduo XR (dapagliflozin/metformin)
- Farxiga (dapagliflozin)
- Glyxambi (empagliflozin/linagliptin)
Now is the time to seek the counsel of our skilled dangerous drug lawyers in Cleveland. Call our firm today at (216) 600-0114.
FDA Provides Warnings in Safety Announcement
In a drug safety announcement, the FDA has taken steps to warn patients about the potential health concerns related to the use of Invokana and similar drugs. They noted that ketoacidosis could develop, which causes the body to produce high levels of blood acids that can lead to diabetic comas or even death. Further, the drugs have been linked to kidney damage and other serious side effects.